Halozyme Therapeutics
HALO
#2189
Rank
โ‚ฌ6.78 B
Marketcap
53,34ย โ‚ฌ
Share price
-1.03%
Change (1 day)
61.10%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ23.89 M-6.29%
2023โ‚ฌ25.5 M-15.59%
2022โ‚ฌ30.2 M38.39%
2021โ‚ฌ21.82 M-6.23%
2020โ‚ฌ23.27 M-44.23%
2019โ‚ฌ41.74 M591.9%
2018โ‚ฌ6.03 M-64.48%
2017โ‚ฌ16.98 M-5.65%
2016โ‚ฌ17.99 M-13.05%
2015โ‚ฌ20.7 M-7.81%
2014โ‚ฌ22.45 M140.61%
2013โ‚ฌ9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ0.14 Mโ‚ฌ13.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ74.57 Mโ‚ฌ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.76 Mโ‚ฌ38.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.96 Mโ‚ฌ0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.14 Mโ‚ฌ72.79 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ22.46 Mโ‚ฌ0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA